- REPORT SUMMARY
- TABLE OF CONTENTS
-
Enasidenib is a drug used to treat relapsed or refractory acute myeloid leukemia in people with specific mutations of the isocitrate dehydrogenase 2 (IDH2) gene, determined by an FDA-approved IDH2 companion diagnostic test
This report offers an overview of the market trends, drivers, and barriers with respect to the China Enasidenib market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Enasidenib market. Detailed analysis of key players, along with key growth strategies adopted by Enasidenib industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Celgene Corporation
By Type:
50mg
100mg
By End-User:
Hospital
Pharmacy
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Enasidenib Market
-
1.3 Market Segment by Type
-
1.3.1 China Enasidenib Market Size and Growth Rate of 50mg from 2016 to 2027
-
1.3.2 China Enasidenib Market Size and Growth Rate of 100mg from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Enasidenib Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Enasidenib Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Enasidenib Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Enasidenib by Major Types
-
3.4.1 Market Size and Growth Rate of 50mg
-
3.4.2 Market Size and Growth Rate of 100mg
4 Segmentation of Enasidenib Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Enasidenib by Major End-Users
-
4.4.1 Market Size and Growth Rate of Enasidenib in Hospital
-
4.4.2 Market Size and Growth Rate of Enasidenib in Pharmacy
5 Market Analysis by Regions
-
5.1 China Enasidenib Production Analysis by Regions
-
5.2 China Enasidenib Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Enasidenib Landscape Analysis
-
6.1 North China Enasidenib Landscape Analysis by Major Types
-
6.2 North China Enasidenib Landscape Analysis by Major End-Users
7 Central China Enasidenib Landscape Analysis
-
7.1 Central China Enasidenib Landscape Analysis by Major Types
-
7.2 Central China Enasidenib Landscape Analysis by Major End-Users
8 South China Enasidenib Landscape Analysis
-
8.1 South China Enasidenib Landscape Analysis by Major Types
-
8.2 South China Enasidenib Landscape Analysis by Major End-Users
9 East China Enasidenib Landscape Analysis
-
9.1 East China Enasidenib Landscape Analysis by Major Types
-
9.2 East China Enasidenib Landscape Analysis by Major End-Users
10 Northeast China Enasidenib Landscape Analysis
-
10.1 Northeast China Enasidenib Landscape Analysis by Major Types
-
10.2 Northeast China Enasidenib Landscape Analysis by Major End-Users
11 Southwest China Enasidenib Landscape Analysis
-
11.1 Southwest China Enasidenib Landscape Analysis by Major Types
-
11.2 Southwest China Enasidenib Landscape Analysis by Major End-Users
12 Northwest China Enasidenib Landscape Analysis
-
12.1 Northwest China Enasidenib Landscape Analysis by Major Types
-
12.2 Northwest China Enasidenib Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Celgene Corporation
-
13.1.1 Celgene Corporation Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Enasidenib Market Size and Growth Rate of 50mg from 2016 to 2027
-
Figure China Enasidenib Market Size and Growth Rate of 100mg from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Enasidenib Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Enasidenib Market Size and Growth Rate of Pharmacy from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Enasidenib Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Enasidenib Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Enasidenib
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Enasidenib by Different Types from 2016 to 2027
-
Table Consumption Share of Enasidenib by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of 50mg
-
Figure Market Size and Growth Rate of 100mg
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Enasidenib by Different End-Users from 2016 to 2027
-
Table Consumption Share of Enasidenib by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Pharmacy
-
Table China Enasidenib Production by Regions
-
Table China Enasidenib Production Share by Regions
-
Figure China Enasidenib Production Share by Regions in 2016
-
Figure China Enasidenib Production Share by Regions in 2021
-
Figure China Enasidenib Production Share by Regions in 2027
-
Table China Enasidenib Consumption by Regions
-
Table China Enasidenib Consumption Share by Regions
-
Figure China Enasidenib Consumption Share by Regions in 2016
-
Figure China Enasidenib Consumption Share by Regions in 2021
-
Figure China Enasidenib Consumption Share by Regions in 2027
-
Table North China Enasidenib Consumption by Types from 2016 to 2027
-
Table North China Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure North China Enasidenib Consumption Share by Types in 2016
-
Figure North China Enasidenib Consumption Share by Types in 2021
-
Figure North China Enasidenib Consumption Share by Types in 2027
-
Table North China Enasidenib Consumption by End-Users from 2016 to 2027
-
Table North China Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure North China Enasidenib Consumption Share by End-Users in 2016
-
Figure North China Enasidenib Consumption Share by End-Users in 2021
-
Figure North China Enasidenib Consumption Share by End-Users in 2027
-
Table Central China Enasidenib Consumption by Types from 2016 to 2027
-
Table Central China Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure Central China Enasidenib Consumption Share by Types in 2016
-
Figure Central China Enasidenib Consumption Share by Types in 2021
-
Figure Central China Enasidenib Consumption Share by Types in 2027
-
Table Central China Enasidenib Consumption by End-Users from 2016 to 2027
-
Table Central China Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Enasidenib Consumption Share by End-Users in 2016
-
Figure Central China Enasidenib Consumption Share by End-Users in 2021
-
Figure Central China Enasidenib Consumption Share by End-Users in 2027
-
Table South China Enasidenib Consumption by Types from 2016 to 2027
-
Table South China Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure South China Enasidenib Consumption Share by Types in 2016
-
Figure South China Enasidenib Consumption Share by Types in 2021
-
Figure South China Enasidenib Consumption Share by Types in 2027
-
Table South China Enasidenib Consumption by End-Users from 2016 to 2027
-
Table South China Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure South China Enasidenib Consumption Share by End-Users in 2016
-
Figure South China Enasidenib Consumption Share by End-Users in 2021
-
Figure South China Enasidenib Consumption Share by End-Users in 2027
-
Table East China Enasidenib Consumption by Types from 2016 to 2027
-
Table East China Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure East China Enasidenib Consumption Share by Types in 2016
-
Figure East China Enasidenib Consumption Share by Types in 2021
-
Figure East China Enasidenib Consumption Share by Types in 2027
-
Table East China Enasidenib Consumption by End-Users from 2016 to 2027
-
Table East China Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure East China Enasidenib Consumption Share by End-Users in 2016
-
Figure East China Enasidenib Consumption Share by End-Users in 2021
-
Figure East China Enasidenib Consumption Share by End-Users in 2027
-
Table Northeast China Enasidenib Consumption by Types from 2016 to 2027
-
Table Northeast China Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Enasidenib Consumption Share by Types in 2016
-
Figure Northeast China Enasidenib Consumption Share by Types in 2021
-
Figure Northeast China Enasidenib Consumption Share by Types in 2027
-
Table Northeast China Enasidenib Consumption by End-Users from 2016 to 2027
-
Table Northeast China Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Enasidenib Consumption Share by End-Users in 2016
-
Figure Northeast China Enasidenib Consumption Share by End-Users in 2021
-
Figure Northeast China Enasidenib Consumption Share by End-Users in 2027
-
Table Southwest China Enasidenib Consumption by Types from 2016 to 2027
-
Table Southwest China Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Enasidenib Consumption Share by Types in 2016
-
Figure Southwest China Enasidenib Consumption Share by Types in 2021
-
Figure Southwest China Enasidenib Consumption Share by Types in 2027
-
Table Southwest China Enasidenib Consumption by End-Users from 2016 to 2027
-
Table Southwest China Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Enasidenib Consumption Share by End-Users in 2016
-
Figure Southwest China Enasidenib Consumption Share by End-Users in 2021
-
Figure Southwest China Enasidenib Consumption Share by End-Users in 2027
-
Table Northwest China Enasidenib Consumption by Types from 2016 to 2027
-
Table Northwest China Enasidenib Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Enasidenib Consumption Share by Types in 2016
-
Figure Northwest China Enasidenib Consumption Share by Types in 2021
-
Figure Northwest China Enasidenib Consumption Share by Types in 2027
-
Table Northwest China Enasidenib Consumption by End-Users from 2016 to 2027
-
Table Northwest China Enasidenib Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Enasidenib Consumption Share by End-Users in 2016
-
Figure Northwest China Enasidenib Consumption Share by End-Users in 2021
-
Figure Northwest China Enasidenib Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Celgene Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corporation
-
Figure Sales and Growth Rate Analysis of Celgene Corporation
-
Figure Revenue and Market Share Analysis of Celgene Corporation
-
Table Product and Service Introduction of Celgene Corporation
-